Loss of MGMT promoter methylation and resistance to cisplatin in non-seminomatous germ cell tumors

被引：1
|
作者：
Moutinho, Catia
Garcia-del-Muro, Xavier
Guino, Elisabet
Vidal, August
Puertas, Sara
Munoz, Clara
Piulats, Josep
Villanueva, Alberto
Esteller, Manel
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-432
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
432
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Brain metastasis from non-seminomatous germ cell tumors of the testisIndications for aggressive treatment
    Maurizio Salvati
    Manolo Piccirilli
    Antonino Raco
    Antonino Santoro
    Riccardo Frati
    Jacopo Lenzi
    Gaetano Lanzetta
    Antonino Agrillo
    Alessandro Frati
    Neurosurgical Review, 2006, 29 : 130 - 137
  • [42] COMPARISON OF 5 ONCODEVELOPMENTAL PROTEINS IN NON-SEMINOMATOUS GERM-CELL TUMORS OF THE TESTES
    BRAUNSTEIN, GD
    THOMPSON, R
    MCINTIRE, KR
    CLINICAL RESEARCH, 1983, 31 (02): : A403 - A403
  • [43] Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumors
    Oosting, S. F.
    de Haas, E. C.
    Links, T. P.
    de Bruin, D.
    Sluiter, W. J.
    de Jong, I. J.
    Hoekstra, H. J.
    Sleijfer, D. T.
    Gietema, J. A.
    ANNALS OF ONCOLOGY, 2010, 21 (01) : 104 - 108
  • [44] Primary mediastinal non-seminomatous germ-cell tumors: From clinics to biology
    Fizazi, K
    Culine, S
    Droz, JP
    LeChevalier, T
    Ruffie, P
    Theodore, C
    BULLETIN DU CANCER, 1997, 84 (03) : 313 - 327
  • [45] DECREASING UTILIZATION OF RPLND FOR CLINICAL STAGE I NON-SEMINOMATOUS GERM CELL TUMORS
    Navai, Neema
    Shikanov, Sergey
    Pisters, Louis
    Eggener, Scott
    JOURNAL OF UROLOGY, 2012, 187 (04): : E305 - E305
  • [46] TUMOR-MARKERS IN PATIENTS WITH NON-SEMINOMATOUS GERM-CELL TUMORS OF THE TESTIS
    WILLEMSE, PHB
    SLEIJFER, DT
    KOOPS, HS
    DEBRUIJN, HWA
    OOSTERHUIS, JW
    BROUWERS, TM
    OCKHUIZEN, T
    MARRINK, J
    ONCODEVELOPMENTAL BIOLOGY AND MEDICINE, 1981, 2 (1-2): : 117 - 128
  • [47] INTENSIVE INDUCTION CHEMOTHERAPY FOR POOR RISK NON-SEMINOMATOUS GERM-CELL TUMORS
    HORWICH, A
    BRADA, M
    NICHOLLS, J
    JAY, G
    HENDRY, WF
    DEARNALEY, D
    PECKHAM, MJ
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (02): : 177 - 184
  • [48] Radiomics model to predict teratoma in metastatic non-seminomatous testicular germ cell tumors
    Scavuzzo, A.
    Crescio, E.
    Figueroa Rodriguez, P. A.
    Duran Chable, D. L.
    Rios Garcia, C. A.
    Jimenez Guedulain, N.
    Calvo Vazquez, I
    Jimenez Rios, M. A.
    EUROPEAN UROLOGY, 2023, 83
  • [49] Results of multimodality therapy in poor risk non-seminomatous germ cell tumors (NSGCT)
    Omuro, Y
    Sasaki, E
    Hayashi, C
    Okamoto, R
    Kobayashi, T
    Maeda, Y
    Sasaki, T
    INTERNATIONAL JOURNAL OF CANCER, 2002, : 430 - 430
  • [50] COMPUTED-TOMOGRAPHY IN PRIMARY NON-SEMINOMATOUS GERM-CELL TUMORS OF THE MEDIASTINUM
    BLOMLIE, V
    LIEN, HH
    FOSSA, SD
    JACOBSEN, AB
    STENWIG, AE
    ACTA RADIOLOGICA, 1988, 29 (03) : 289 - 292
12345